Literature DB >> 27123080

Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells.

Zhe Guo1, Jing-Hang Jiang2, Jun Zhang3, Hao-Jie Yang4, Yan-Ping Zhong5, Jie Su5, Ri-Rong Yang6, LE-Qun Li4, Bang-DE Xiang4.   

Abstract

Substantial evidence implicates that low-abundance cancer stem cells (CSCs) are responsible for tumor metastasis and recurrence in hepatocellular carcinoma (HCC). Side population (SP) cells possess typical CSCs-like features, and are frequently considered as a special subpopulation in which CSCs are enriched and in studies may be considered as a substitute for CSCs. The aim of the present study was to examine the abundance of SP cells in human HCC cell lines with different metastatic potentials and compare their CSC-like, tumorigenic and invasive properties with those of the main population (MP) cells. An experimental system is described for identifying SP cells and analyzing their CSC-like properties. The relative abundance of SP cells correlated directly with the metastatic potential of the HCC cell line: HCCLM3, 16.3±2.2%; MHCC97-H, 8.4±0.7%; MHCC97-L, 4.7±0.5%; and Huh7, 1.0±0.3% (P<0.05). SP cells isolated from HCCLM3 cultures showed significantly higher proliferation rates and clonogenicity than the corresponding MP cells, in addition to higher migration and invasive abilities in vitro and greater tumorigenicity in mice. Expression levels of all CSC-associated genes tested, except EpCAM and Oct4, were significantly higher in SP cells. The findings revealed that the proportion of SP cells correlates with metastatic potential, and SP cells demonstrated the characteristics expected of CSCs, implicating them in HCC metastasis. Further studies on the identification and characterization of SP cells using clinical HCC specimens will contribute to the understanding of how SP cells are involved in these disease processes.

Entities:  

Keywords:  cancer stem cell; hepatocellular carcinoma; metastasis; recurrence; side population

Year:  2016        PMID: 27123080      PMCID: PMC4841100          DOI: 10.3892/ol.2016.4343

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

Review 1.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

2.  Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.

Authors:  Zhe Guo; Le-Qun Li; Jing-Hang Jiang; Chao Ou; Li-Xia Zeng; Bang-De Xiang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 3.  Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.

Authors:  Magda Kucia; Ryan Reca; Katarzyna Miekus; Jens Wanzeck; Wojtek Wojakowski; Anna Janowska-Wieczorek; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Stem Cells       Date:  2005-05-11       Impact factor: 6.277

4.  Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.

Authors:  Jae Min Chun; Hyung Jun Kwon; Junho Sohn; Sang Geol Kim; Ji-Young Park; Han Ik Bae; Young Kook Yun; Yoon Jin Hwang
Journal:  J Surg Oncol       Date:  2010-12-22       Impact factor: 3.454

5.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

6.  Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.

Authors:  Zheng Zhu; Xiangfang Hao; Mingxia Yan; Ming Yao; Chao Ge; Jianren Gu; Jinjun Li
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

7.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Authors:  Maria M Ho; Alvin V Ng; Stephen Lam; Jaclyn Y Hung
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

8.  MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.

Authors:  X T Xu; Q Xu; J L Tong; M M Zhu; F Nie; X Chen; S D Xiao; Z H Ran
Journal:  Br J Cancer       Date:  2012-03-27       Impact factor: 7.640

9.  Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes.

Authors:  Anke Van den Broeck; Hugo Vankelecom; Wouter Van Delm; Lies Gremeaux; Jasper Wouters; Joke Allemeersch; Olivier Govaere; Tania Roskams; Baki Topal
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

10.  A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.

Authors:  Alessia Gagliardi; Nicholas P Mullin; Zi Ying Tan; Douglas Colby; Anastasia I Kousa; Florian Halbritter; Jason T Weiss; Anastasia Felker; Karel Bezstarosti; Rebecca Favaro; Jeroen Demmers; Silvia K Nicolis; Simon R Tomlinson; Raymond A Poot; Ian Chambers
Journal:  EMBO J       Date:  2013-07-26       Impact factor: 11.598

View more
  10 in total

1.  Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer.

Authors:  Po-Kai Chuang; Michael Hsiao; Tsui-Ling Hsu; Chuan-Fa Chang; Chung-Yi Wu; Bo-Rui Chen; Han-Wen Huang; Kuo-Shiang Liao; Chen-Chun Chen; Chi-Long Chen; Shun-Min Yang; Chiung Wen Kuo; Peilin Chen; Ping-Tzu Chiu; I-Ju Chen; Jiann-Shiun Lai; Cheng-Der Tony Yu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

Review 2.  Road to stemness in hepatocellular carcinoma.

Authors:  Teresita Nj Flores-Téllez; Saúl Villa-Treviño; Carolina Piña-Vázquez
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

3.  Increased Oxidative Phosphorylation Is Required for Stemness Maintenance in Liver Cancer Stem Cells from Hepatocellular Carcinoma Cell Line HCCLM3 Cells.

Authors:  Ge Liu; Qing Luo; Hong Li; Qiuping Liu; Yang Ju; Guanbin Song
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

4.  Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.

Authors:  Zheng-Yuan Xie; Mao-Sheng Liu; Cong Zhang; Peng-Cheng Cai; Zhi-Hua Xiao; Fen-Fen Wang
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

5.  CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance.

Authors:  Min Xu; Shiji Fang; Jingjing Song; Minjiang Chen; Qianqian Zhang; Qiaoyou Weng; Xiaoxi Fan; Weiqian Chen; Xulu Wu; Fazong Wu; Jianfei Tu; Zhongwei Zhao; Jiansong Ji
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

6.  Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.

Authors:  Weiyang Lou; Jing Chen; Bisha Ding; Danni Chen; Huilin Zheng; Donghai Jiang; Liang Xu; Chang Bao; Guoqiang Cao; Weimin Fan
Journal:  J Transl Med       Date:  2018-09-29       Impact factor: 5.531

Review 7.  SIRT1 in the Development and Treatment of Hepatocellular Carcinoma.

Authors:  Marius Farcas; Andrei-Alexandru Gavrea; Diana Gulei; Calin Ionescu; Alexandru Irimie; Cristina S Catana; Ioana Berindan-Neagoe
Journal:  Front Nutr       Date:  2019-09-25

8.  LncRNA RSU1P2-microRNA let-7a-Testis-Expressed Protein 10 axis modulates tumorigenesis and cancer stem cell-like properties in liver cancer.

Authors:  Jia-Hong Liang; Qiao-Dong Xu; Song-Gang Gu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29.

Authors:  Sara Soltanian; Helia Riahirad; Athareh Pabarja; Elham Jafari; Behjat Kalantari Khandani
Journal:  Daru       Date:  2018-09-12       Impact factor: 3.117

10.  The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma.

Authors:  Zide Chen; Jiehua Chen; Hongyan Liu; Wei Dong; Xuan Huang; Dajun Yang; Jinlin Hou; Xiaoyong Zhang
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.